[Mechanism of Atractylodes macrocephala against Alzheimer's disease via regulating lysophagy based on LKB1-AMPK-TFEB

Li-Min Wu1, Jie Zhao2, Xiao-Wei Zhang2

  • 1Academy of Chinese Medical Sciences, Henan University of Traditional Chinese Medicine Zhengzhou 450046,China Pharmacy College, Henan University of Traditional Chinese Medicine Zhengzhou 450046,China.

Insights

Atractylodes macrocephala (AM) reduces amyloid-beta (Aβ) levels in Alzheimer's disease models by activating the LKB1-AMPK-TFEB pathway, enhancing lysosome function and promoting Aβ degradation.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Molecular Biology

Background:

  • Alzheimer's disease (AD) is characterized by the accumulation of amyloid-beta (Aβ), resulting from amyloid precursor protein (APP) cleavage.
  • Investigating natural compounds for AD treatment is crucial due to the disease's prevalence and limited therapeutic options.

Purpose of the Study:

  • To investigate the mechanism of Atractylodes macrocephala (AM) in combating Alzheimer's disease (AD).
  • To explore the role of the LKB1-AMPK-TFEB pathway in AM's neuroprotective effects against Aβ accumulation.

Main Methods:

  • Utilized AD transgenic Caenorhabditis elegans (CL2241) to assess memory and Aβ levels.
  • Employed in vitro assays using mouse neuroblastoma (N2a) cells transfected with APP plasmid.
  • Quantified Aβ, APP, TFEB transcriptional activity, lysosomal activity, and autophagy flux using ELISA, Western blot, fluorescence microscopy, and reporter gene assays.
  • Analyzed protein and mRNA expression of key pathway components (LKB1, AMPK, TFEB, LC3, LAMP2) via Western blot and RT-PCR.

Main Results:

  • Atractylodes macrocephala (AM) reduced Aβ levels and APP expression in both C. elegans and N2a cells.
  • AM treatment enhanced TFEB transcriptional activity, lysosomal activity, and autophagy flux, indicated by increased LC3-II/LC3-I ratio and mRFP-GFP-LC3 fluorescence.
  • AM upregulated the expression of TFEB, LAMP2, Beclin1, LKB1, p-AMPK, and p-ACC, suggesting activation of the LKB1-AMPK-TFEB pathway.

Conclusions:

  • Atractylodes macrocephala (AM) demonstrates neuroprotective effects against Alzheimer's disease (AD) pathology by reducing Aβ accumulation.
  • AM's mechanism involves the activation of the LKB1-AMPK-TFEB pathway, leading to enhanced lysophagy and degradation of APP and Aβ.
  • These findings suggest AM as a potential therapeutic agent for Alzheimer's disease (AD).

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
635
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
248
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
79.5K
Long-term Depression01:03

Long-term Depression

Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
2.6K
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
6.7K
Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.5K